Characterization and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large-cell lymphoma
Open Access
- 29 May 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (41) , 26543-26555
Abstract
Characterization and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large-cell lymphoma Characterization and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large-cell lymphomaKeywords
This publication has 44 references indexed in Scilit:
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast CancerNew England Journal of Medicine, 2013
- Genomic EWS-FLI1 Fusion Sequences in Ewing Sarcoma Resemble Breakpoint Characteristics of Immature Lymphoid MalignanciesPLOS ONE, 2013
- Plasma Cell-Free DNA in Paediatric LymphomasJournal of Cancer, 2013
- Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosisLeukemia, 2012
- Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II StudyJournal of Clinical Oncology, 2012
- Single-Drug Vinblastine As Salvage Treatment for Refractory or Relapsed Anaplastic Large-Cell Lymphoma: A Report From the French Society of Pediatric OncologyJournal of Clinical Oncology, 2009
- Impact of the Methotrexate Administration Dose on the Need for Intrathecal Treatment in Children and Adolescents With Anaplastic Large-Cell Lymphoma: Results of a Randomized Trial of the EICNHL GroupJournal of Clinical Oncology, 2009
- Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: Final results of children's cancer group study 5941Pediatric Blood & Cancer, 2009
- Human Chromosomal Translocations at CpG Sites and a Theoretical Basis for Their Lineage and Stage SpecificityCell, 2008
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008